Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Autism study aims to end guesswork in treatment

NCT ID NCT05590715

Knowledge-focused Sponsor: Stalicla SA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study is looking at 1,500 people with autism to find biological and clinical markers that define specific subtypes. The goal is to identify which patients might respond best to certain medications. Participants must have a formal autism diagnosis and detailed early health records.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2022

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male or female individuals with an autism diagnosis as defined by the DSM-5, adults (from 18 to 65 years of age, inclusive) and adolescents (from 12 to 17 years of age, inclusive).

Ages

12 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants previously diagnosed with ASD (DSM-5) * Available well-documented health records within the first 2 years of life * Participants must have a parent or reliable caregiver who agrees to provide information about the participant * Participants willing and consenting or assenting to participate. Exclusion Criteria: * Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment. * If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    15 sites in 3 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Alpine Research Organization

    RECRUITING

    Clinton, Utah, 84015, United States

  • BioPhase Research

    TERMINATED

    Miami, Florida, 33137, United States

  • California Neuroscience Research

    RECRUITING

    Sherman Oaks, California, 91403, United States

  • Children's Health Queensland Hospital and Health Service

    NOT_YET_RECRUITING

    South Brisbane, Queensland, 4101, Australia

  • Flinders Medical Centre

    NOT_YET_RECRUITING

    Bedford Park, South Australia, 5042, Australia

  • Golden Hearts Diagnostic

    WITHDRAWN

    Alamogordo, New Mexico, 88210, United States

  • Hospital Clinic of Barcelona

    RECRUITING

    Barcelona, 8036, Spain

  • Hospital General Universitario Dr Balmis

    RECRUITING

    Alicante, 30010, Spain

  • Hospital Infantil Universitario Nino Jesus (HIUNJS)

    RECRUITING

    Madrid, 28009, Spain

  • Hospital Universitario Puerta De Hierro Majadahonda

    TERMINATED

    Majadahonda, 28222, Spain

  • Hospital universitario Infanta Leonor

    RECRUITING

    Madrid, 28031, Spain

  • Hospital Álvaro Cunqueiro

    RECRUITING

    Vigo, 36213, Spain

  • Locuspsych

    RECRUITING

    Melbourne, Victoria, 3004, Australia

    Contact Email: •••••@•••••

  • Mater Misericordiae Limited

    NOT_YET_RECRUITING

    South Brisbane, Queensland, 4101, Australia

  • Murdoch Children's Research Institute

    NOT_YET_RECRUITING

    Parkville, Victoria, 3052, Australia

  • Policlina Gipuzkoa

    ACTIVE_NOT_RECRUITING

    San Sebastián, 20014, Spain

  • Red Oak Psychiatry Associates

    WITHDRAWN

    Houston, Texas, 77090, United States

  • Rush University Medical Center

    RECRUITING

    Chicago, Illinois, 60612, United States

  • SARRC

    RECRUITING

    Phoenix, Arizona, 85006, United States

  • The Angel Medical Research

    WITHDRAWN

    Miami Lakes, Florida, 33016, United States

  • University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders

    RECRUITING

    Columbia, Missouri, 65211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.